differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: An analysis of formalin-evoked C-fos expression

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 801-809

  Gogas, K R ^a,d   Levine, J D ^c   Basbaum, A I ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; ENADOLINE; FORMALDEHYDE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; NARCOTIC ANALGESIC AGENT; PROTEIN C FOS; PYRROLIDINE DERIVATIVE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; MALE; PHYSIOLOGY; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; BENZOFURANS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; MALE; NALOXONE; PROTO-ONCOGENE PROTEINS C-FOS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 0030087697     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. 3H]U69593 labelled kappa opioid binding sites in the rat spinal cord. Brain Res. 502: 149-157, 1989
2. ATWEH, S. F. AND KUHAR, M. J.: Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res. 124: 53-67, 1977.
3. BARTON, C., BASBAUM, A. I. AND FIELDS, H. L.: Dissociation of supraspinal and spinal actions of morphine: A quantitative evaluation. Brain Res. 188: 487-498, 1980.
4. BASBAUM, A. I. AND FIELDS, H. L.: Endogenous pain control mechanisms: review and hypothesis. Ann. Neurol. 4: 451-462, 1978.
5. BASBAUM, A. I. AND FIELDS, H. L., Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7: 309-338, 1984.
6. BENNETT, G. J. AND MAYER, D. J.: Inhibition of spinal cord interneurons by narcotic injections. Brain Res. 172: 243-257, 1979.
7. BESSON, J -M. AND CHAOUCH, A.: Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67: 67-186, 1987.
8. BOUHASSIRA, D., VILLANUEVA, L. AND LEBARS, D.: Intracerebroventricular morphine decreases descending inhibitions acting on lumbar dorsal horn neuronal activities related to pain in the rat. J. Pharmacol. Exp. Ther. 247: 332-342, 1988.
9. CALCAGNETTI, D. J., HELMSTETTER, F. J. AND FANSELOW, M. S.: Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin test. Eur. J. Pharmacol. 153: 117-132, 1988.
10. CLARK, C. R., BIRCHMORE, B., SHARIF, N A., HUNTER, J. C., HILL, R. G. AND HUGHES, J.: PD117302: a selective agonist for the κ-opioid receptor. Br. J. Pharmacol. 93: 618-626, 1988.
11. Du, H. J., KITAIIATA, L. M., THALHAMMER, J. G. AND ZIMMERMAN, M.: Inhibition of nociceptive responses in the cat's spinal dorsal horn by electrical stimulation and morphine microinjection in nucleus raphe magnus. Pain 19: 249-257, 1984.
12. DUBUISSON, D. AND DENNIS, S G.: The formahn test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174, 1977.
13. DUNHAM, N. W. AND MIYA, T. S.: A note on a simple apparatus for detecting neurological deficit in mice. J. Am. Pharm. Assoc. 46: 208-209, 1957.
14. FADEN, A. I. AND JACOBS, T. P.: Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action. Br. J. Pharmacol. 81: 271-276, 1984.
15. FLEETWOOD-WALKER, S. M., MITCHELL, R., HOPE, P. O., MALONEY, V. AND IGGO, A.: An α2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res. 334: 243-254, 1985.
16. GEBHART, G. F., SANDKUHLER, J., THALHAMMER, J. G. AND ZIMMERMAN, M.: Stimulation and morphine in the PAG: inhibition in the spinal cord of nociceptive information by electrical stimulation and morphine microinjection at identical sites in the midbrain of the cat. J. Neurophysiol 51: 75-89, 1989.
17. GOGAS, K. R., CHO, H J., BOTCHKINA, G. I., LEVINE, J. D. AND BASBAUM, A. I.: Inhibition of noxious stimulus-evoked pain behaviors and neuronal FOS-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain, in press.
18. GOGAS, K. R., PRESLEY, R. W., LEVINE, J. D. AND BASBAUM, A. I.: The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: Correlation of nociceptive behavior and c-fos expression. Neuroscience 42: 617-628, 1991.
19. HAMMOND, D. L., PRESLEY, R., GOGAS, K. R., BASBAUM, A. I.: Morphine or U50488 suppresses fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious viseral stimulus in the rat. J. Comp. Neurol. 315: 244-253, 1992.
20. HAN, J.-S. AND XIE, C.-W.: Dynorphin: Potent analgesic effect in the spinal cord of the rat. Life Sci. 31: 1781-1784, 1982.
21. LPH61-64 possessing selective agonist activity at μ,-opiate receptors Eur. J. Pharmacol. 70: 531-540, 1981.
22. HERMAN, B. H. AND GOLDSTEIN, A.: Antinociception and paralysis induced by intrathecal dynorphin A. J Pharmacol Exp. Ther. 232: 27-32, 1986.
23. HERRERO, J. F. AND HEADLEY, P. M.: Functional evidence for multiple receptor activation by κ-ligands in the inhibition of spinal nociceptive reflexes in the rat Br. J. Pharmacol. 110; 303-309, 1993.
24. HORAN, P. J., DECOSTA, B. R., RICE, K., HAASETH, R. C., HRUBY, V. J. AND PORRECA, F : Differential antagonism of bremazocine- and U69593-induced antinociception by quadrazocine: Further functional evidence of opioid κ receptor multiplicity in the mouse. J. Pharmacol. Exp. Ther. 206: 926-933, 1993.
25. HUNTER, J. C , LEIGHTON, G. E., MEECHAM, K. G., BOYLE, S. J., HORWELL, D. C., REES, D. C. AND HUGHES, J.: CI-977, a novel and selective agonist for the κ-opioid receptor. Br. J. Pharmacol. 101: 183-189, 1990.
26. JONES, S. L.: Noradrenergic modulation of noxious heat-evoked fos-like immunoreactivity in the dorsal horn of the rat sacral spinal cord. J. Comp. Neurol. 325: 435-445, 1992.
27. JONES, S. L. AND GEBHART, G. F., Spinal pathways mediating tonic coerulospinal, and raphe-spinal descending inhibition in the rat. J. Neurophysiol. 58: 138-159, 1987.
28. KEHL, L J., GOGAS, K. R., LICHTBLAU, L., POLLOCK, C. H., MAYES, M., BASBAUM, A. I. AND WILCOX, G. L.: The NMDA antagonist MK-801 reduces noxious stimulus-evoked Fos expression in the spinal dorsal horn. In Pain Research and Clinical Management, Proceedings of the VIth World Congress on Pain, ed. by M. R. Bond, J. E. Charlton and C. J. Woolf,pp. 307-311, Elsevier, Amsterdam, 1991.
29. 3H]U-69593 a highly selective ligand for the kappa opioid receptor. Eur. J. Pharmacol. 109: 281-284, 1985.
30. LAMBERT, P. D., WOODRUFF, G. N., HUGHES, J. AND HUNTER, J. C.: Inhibition of L-glutamate release: A possible mechanism of action for the neuroprotective effects of the kappa-selective agonist CI-977. Mol. Neuropharmacol. 1: 77-82, 1991.
31. LAMOTTE, C., PERT, C. B. AND SNYDER, S. H.: Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res. 112: 407-412, 1976.
32. LEIGHTON, G. E., RODRIGUEZ, R. G., HILL, R. G. AND HUGHES, J.: κ-opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br. J. Pharmacol. 93: 553-560, 1988.
33. MANSOUR, A., KHACHATURIAN, H., LEWIS, M. E., AKIL, H. AND WATSON, S J.: Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7: 2445-2464, 1987.
34. MANSOUR, A., Fox, C. A., MENG, F., AKIL, H. AND WATSON, S J.: Kappa 1 receptor mRNA Distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol Cell. Neurosci 5: 124-44, 1994a.
35. MANSOUR, A., Fox, C. A., THOMPSON, R. C., AKIL, H. AND WATSON, S. J.: Mu-opioid receptor mRNA expression in the rat CNS: Comparison to mu receptor binding. Brain Res. 643: 245-265, 1994b.
36. 2]deltorphin II in mice Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258: 583-587, 1991.
37. MOSBERG, H. I., HURST, R., HRUBY, V.,J., GEE, K., YAMAMURA, H. I., GALLIGAN, J. AND BURKS, T.: Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl Acad. Sci. U.S.A. 80: 5871-5874, 1983.
38. PIERCEY, M. F., LAHTI, R. A., SCHROEDER, L. A., EINSPAHR, F. J. AND BARSUHN, C.: U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse. Life Sci. 31: 1197-1200, 1982.
39. PINNOCK, R D.: Activation of κ-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphe nucleus in vitro. Brain Res. 583: 237-246, 1992a.
40. PINNOCK, R. D.: A highly selective κ-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro. Neuroscience 47: 87-94, 1992b.
41. POAT, J. A., PETTERSSON, E. K. E., HUNTER, J. C. AND HUGHES, J.: Immediate early gene expression in the rat-paw formalin model: The effect of Enadoline. Soc. Neurosci. Abstr. 19: 1565, 1993.
42. PORTOGHESE, P. S., LIPKOWSKI, A. W. AND TAKEMORI, A. E.: Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci 40: 1287-1292, 1987.
43. PRESLEY, R. W., MENETREY, D., LEVINE, J. D. AND BASBAUM, A. I.: Systemic morphine suppresses noxious stimulation-evoked fos protein-like immunoreactivity in the rat spinal cord. J. Neurosci. 10: 323-335, 1990.
44. SINGII, L., VASS, C. A., HUNTER, J. C., WOODRUFF, G. N. AND HUGHES, J : The anticonvulsant action of CI-977, a selective kappa-opioid receptor agonist: A possible involvement of the glycine/NMDA receptor complex. Eur. J. Pharmacol. 191: 477-480, 1990.
45. SOFUOGLU, M., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Cross-tolerance studies in the spinal cord of β-fna-treated mice provides further evidence for delta opioid receptor subtypes. Life Sci. 49: PL-153-PL-156, 1991.
46. 4]Deltorphin. J. Pharmacol. Exp. Ther. 266: 820-828, 1993.
47. STEWART, P. E. AND HAMMOND, D. L.: Activation of spinal delta-1. or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J. Pharmacol. Exp. Ther. 268: 701-708, 1994.
48. SUAREZ-ROCA, H. AND MAIXNER, W.: Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Ther. 264: 648-653, 1993.
49. SULLIVAN, A. F., DASHWOOD, M. R. AND DICKENSON, A. H.: α2-adrenoceptor modulation of nociception in rat spinal cord: Location, effects and interactions with morphine. Eur. J. Pharmacol. 138: 169-177, 1987.
50. SUTTER, K. A , MIASKOWSKI, C., TAIWO, Y. O. AND LEVINE, J. D.: Analgesic synergy and improved motor function produced by combinations of μ-δ and μ-κ opioids Brain Res. 530: 290-294, 1990.
51. TAKEMORI, A. E., BEGONLA, Y. H O., NAESETH, J. S., PORTOGHESE, P. S.: Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther, 246: 255-258, 1988.
52. TALLARIDA, R J. AND JACOBS, L. S : The Dose Response Relationship in Pharmacology, Springer, New York, 1979.
53. TORTELLA, F. C., ECHEVARRIA, E., LIPKOWSKI, A. W., TAKEMORI, A. E., PORTOGHESE, P S. AND HOLADAY, J. W., Selective kappa antagonist properties of norbinaltorphimine in the rat MES seizure model. Life Sci. 44: 661-665, 1989.
54. TULUNAY, F. C., JEN, M. F., CHANG, J. K., LOH, H. H. AND LEE, N. M.: Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. J. Pharmacol. Exp. Ther 219: 296-298, 1981.
55. VONVOIGHTLANDER, P. F., LAHTI, R. A. AND LUDENS, J. H.: U-50,488h: A selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224: 7-12, 1983.
56. WARD, S. J. AND TAKEMORI, A E.: Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. J. Pharmacol. Exp. Ther. 224: 525-530, 1983.
57. WHEELER-ACETO, H. AND COWAN, A.: Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 104: 35-44, 1991.
58. YAKSH, T. L.: Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol. Biochem. Behav. 22: 845-858, 1985.
59. YAKSH, T. L. AND NOUEIHED, R.: The physiology and pharmacology of spinal opiates. Annu. Rev. Pharmacol Toxicol. 25: 433-462, 1985.
60. YASUDA, K., RAYNOR, K , KONG, H., BREDER, C. D., TAKEDA, J., RESINE, T. AND BELL, G. I.: Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. U.S.A. 90: 6736-6740, 1993.
61. ZASTAWNY, R. L., GEORGE, S. R., NGUYEN, T., CHENG, R., TSATSOS, J., BRIONESURBINA, R. AND O'DOWD, B. F.: Cloning, characterization and distribution of a mu-opioid receptor in rat brain. J. Neurochem. 62: 2099-2105, 1994.